| Author (Corporate) | European Commission: Press and Communication Service |
|---|---|
| Series Title | Press Release |
| Series Details | IP/04/985 (22.7.04) |
| Publication Date | 22/07/2004 |
| Content Type | News |
|
A team of European researchers plans to perfect techniques for producing antibodies and vaccines, obtained from plants, to prevent and treat major human diseases, such as AIDS, rabies and TB. The idea is to use genetically modified (GM) crops eventually to produce plant-based pharmaceuticals. Pharma-Planta is a consortium of eleven European countries and South Africa which, with the aid of EU funding, plans to produce vaccines and other treatments for major diseases, such as HIV/AIDS, rabies and tuberculosis. The project, led by the Fraunhofer Institute for molecular biology and ecology in Aachen (Germany), with scientific co-ordination by St George's Hospital Medical School in London (UK), hopes to start clinical trials by the end of the funding period in 2009. |
|
| Source Link | Link to Main Source http://europa.eu/rapid/pressReleasesAction.do?reference=IP/04/985&format=HTML&aged=0&language=EN&guiLanguage=en |
| Related Links |
|
| Subject Categories | Business and Industry, Culture, Education and Research |
| Countries / Regions | Europe |
